News archive for Faculty of Medicine

Collage of photos from the CCBIO annual symposium 2024.

Discussing current cancer biomarkers at CCBIO’s 12th Annual Symposium (2024) (29.05.2024)

The 12th CCBIO Annual Symposium took place May 14-15, 2024, at Solstrand outside of Bergen in excellent weather, facilitating a radiant frame for networking and meetings in the sunshine during the breaks. The program showcased current cancer biomarker research as well as taking a step back considering global perspectives on cancer.

Congratulations to PhD Annabel Ohldieck for very good performance at her midway evaluation! (29.05.2024)

Associate professors Tine Karlsen and Gerhard Sulo evaluated PhD fellow Annabel Ohldieck’s studies on sex differences in the association of blood pressure with organ damage

Green sheet of paper with an inscription ADHD medications and pills.

This year's publication at Department of Global Public Health and Primary Care (28.05.2024)

Kari Klungsøyr received the award for publication of the year on the institute's day on 8 May 2024

WORLD MS DAY: MAY 30th (27.05.2024)

Did you know that UiB coordinates a European initiative to target the cause of MS?

5 quick questions about Epstein-Barr-virus and Multiple Sclerosis (27.05.2024)

Honorary Doctor Alberto Ascherio led the research that demonstrated a connection between the Epstein-Barr virus and Multiple Sclerosis (MS). Here he answers five key questions about this topic.

International experts on leprosy gathered in Bergen (23.05.2024)

UiB is hosting the "Zero Transmission Symposium" this week where researchers working towards zero leprosy are gathered to to discuss recent developments and identify remaining knowledge gaps. Despite ongoing efforts, more than 200,000 people worldwide are diagnosed with the disease annually.

Real-world data shows that rituximab is more effective than cladribine (22.05.2024)

During 2017-2019, systematic differences in high efficacy MS-treatment strategies were preferred in Oslo (cladribine) and Bergen (rituximab). Comparisons of long-term (median 4.5 years) effects from these different treatments showed a 2.7 higher risk for new MRI disease activity after four years in the cladribine group (n=132) compared to rituximab group (n=168).

Opening of DRIV, Center for research on women’s health (21.05.2024)

Professor Eva Gerdts explained the need for more research on women’s health during the opening of the DRIV Center for research on Women’s health. It is important to have a modern vision on women’s health and move out of bikini medicine

Can kynurenine be used as a biomarker for ADHD and depression? (15.05.2024)

Tore Ivar Malmei Aarsland will defend his PhD degree at the University of Bergen on 21 May 2024 with the thesis "Tryptophan and kynurenine pathway metabolites in neuropsychiatric disorders".

Picture from seminar Female Heart Workshop 2024

Female Heart Workshop 2024 (10.05.2024)

A fantastic and inspirational workshop of high scientific quality with participants from all over Norway and invited international experts from Spain, Italy and Iceland